Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-043-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 4 September 2006 to 31 October 2006
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in accordance with generally accepted scientific principles, possibly with incomplete reporting or methodological deficiencies, which do not affect the quality of relevant results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- (2R)-1-hydroxy-8,8,10,10,12,12,14,14,16,16-decamethyl-4,9,11,13,15-pentaoxa-8,10,12,14,16-pentasilaicosan-2-yl 2-methylprop-2-enoate; (2R)-2-hydroxy-8,8,10,10,12,12,14,14,16,16-decamethyl-4,9,11,13,15-pentaoxa-8,10,12,14,16-pentasilaicosan-1-yl 2-methylprop-2-enoate; (2S)-1-hydroxy-8,8,10,10,12,12,14,14,16,16-decamethyl-4,9,11,13,15-pentaoxa-8,10,12,14,16-pentasilaicosan-2-yl 2-methylprop-2-enoate; (2S)-2-hydroxy-8,8,10,10,12,12,14,14,16,16-decamethyl-4,9,11,13,15-pentaoxa-8,10,12,14,16-pentasilaicosan-1-yl 2-methylprop-2-enoate
- EC Number:
- 700-043-1
- Molecular formula:
- C24H56O8Si5
- IUPAC Name:
- (2R)-1-hydroxy-8,8,10,10,12,12,14,14,16,16-decamethyl-4,9,11,13,15-pentaoxa-8,10,12,14,16-pentasilaicosan-2-yl 2-methylprop-2-enoate; (2R)-2-hydroxy-8,8,10,10,12,12,14,14,16,16-decamethyl-4,9,11,13,15-pentaoxa-8,10,12,14,16-pentasilaicosan-1-yl 2-methylprop-2-enoate; (2S)-1-hydroxy-8,8,10,10,12,12,14,14,16,16-decamethyl-4,9,11,13,15-pentaoxa-8,10,12,14,16-pentasilaicosan-2-yl 2-methylprop-2-enoate; (2S)-2-hydroxy-8,8,10,10,12,12,14,14,16,16-decamethyl-4,9,11,13,15-pentaoxa-8,10,12,14,16-pentasilaicosan-1-yl 2-methylprop-2-enoate
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): Compound A
-Lot numbeer: T060620
- Appearance: clear to mild yellowish transparent liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River laboratories Japan, Inc
- Age at study initiation: 7 weeks
- Weight at study initiation: 160-190 g
- Fasting period before study: From the afternoon of the day before the administration unitl the observation at 4 hours after the administration.
- Housing: Metal rat cage 380 x 240 x 170 (mm)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Allowable range 19-25°C. Actual temperature measured during the quarantine and acclimation period: 22.7-23.3°C.
Actual temperature measured during the administration and observation period: 22.0-23.1°C
- Humidity (%): Allowable range 40-60
Actual humidity measured during the administration and observation period: 51.0–57.9%RH
- Air changes (per hr): Over 10 times/hour
- Photoperiod (hrs dark / hrs light): 12 hours light, 12 hours dark.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: sesame oil
- Details on oral exposure:
- Dosing solution was prepared on the day of administration and used immediately afterpreparation.
(1) Test article: Compound A
(2) Administration solvent
Name: Japanese Pharmacopoeia Sesame oil
Specification: Japanese Pharmacopoeia
Manufacturer: Yoshida Pharmaceutical Co., Ltd.
Lot number: 659
(3) Preparation method: Compound A was measured for the amount needed, and then dosing solution was prepared for the predetermined concentration by adding the sesame oil.
Administration
Administration was preformed the day after the grouping.
(1) Age of animals at administration
Study 1: 8 weeks of age
Study 2: 9 weeks of age
Study 3: 10 weeks of age
Study 4: 10 weeks of age
(2) Administration route and the reasons for choice
Oral administration.
The reasons for selection of the administration route: followed OECD revised 423.
(3) Administration method and the reasons for selection
The administration dose was 5 mL/kg. The predetermined amount of dosing solution was given orally via gavage using syringes with oral feeding needles for rats. The reasons for selection for administration method: it is a standard method for oral administration.
(4) Administration period, frequency, and time slot and the reasons for selection
Administration was once on Day 1 and performed in the morning (9:24–9:53).
The reasons for selection: followed OECD revised 423.
(5) Fasting
Animals were fasted from the afternoon (16:20–16:30) of the day before administration until the observation at 4 hours after the administration. After the observation, feeding (ad libitum) was resumed - Doses:
- 300 mg/kg
2000 mg/kg - No. of animals per sex per dose:
- 6 at 300 mg/kg
6 at 2000 mg/kg - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The observation period was for 14 days, from Day 1 (administration day) to Day 14, and viability and general condition were observed immediately at the administration (administration–15 minutes after), 30 minutes, 1 hour, 2 hours, 4 hours, and 8 hours after the administration. On the days except for the administration day, animals were observed for viability and secondarily general condition in the morning (8:30–12:00) while only viability was observed in the afternoon (15:00–17:00). However, observation of viability and general condition was conducted only once in the morning (8:30–12:00) on holidays.
Bodyweight: Animals were weighed in the morning of Day 1, 2, 3, 4, 5, 6, 7, 10, and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, histopathology. - Statistics:
- Statistical method used for data processing and analysis was not performed.
Results and discussion
- Preliminary study:
- In order to evaluate acute toxicity, 300 mg/kg was administered once orally as initial dose (study 1) to 3 female rats. Since no death was confirmed in the study further studies were performed in incremental steps.
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No statistical method for 95% CL provided.
- Mortality:
- There was no death in any study and dose level.
Study 1: 300 mg/kg
Study 2: 300 mg/kg
Study 3: 2000 mg/kg
Study 4: 2000 mg/kg - Clinical signs:
- other: No specific abnormality was seen in general condition.
- Gross pathology:
- No specific abnormalities were seen in the anatomic pathology examinations.
- Other findings:
- - Potential target organs: N/A
- Other observations: In study 1 where 300 mg/kg was administered, loose stool was observed in 2 out of 3 cases at only 2 hours after adminstration.
- Organ weights: There were no gross changes observed.
- Histopathology: No abnormalities
Any other information on results incl. tables
No death was confirmed in any of the studies with 300 mg/kg and 2000 mg/kg administration, and no specific abnormality was seen in general condition, weight changes, or anatomic pathology examination. Based on the above results, LD50 of Compound A in female rats was 2000 mg/kg and above and it was considered not applicable as poisonous and deleterious substance.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- LD50 in female rats was 2000 mg/kg and above and it was considered not acutely by oral ingestion.
- Executive summary:
In an acute oral toxicity study (OECD 423), groups of female Crl:CD(SD) rats were given a single oral dose of Mono(hydroxymethacryloxypropoxypropyl) Polydimethylsiloxane in sesame oil at doses of 300 or 2000 mg/kg bw. Animals were then observed for 14 days.
Oral LD50
Females = greater than 2000 mg/kg bw
The substance is of Low Toxicity based on the LD50 in female rats.
No death was confirmed in any of the studies with 300 mg/kg and 2000 mg/kg administration, and no specific abnormality was seen in general condition, weight changes, or anatomic pathology examination.
This acute oral study is classified as acceptable. It does satisfy the guideline requirement for an acute oral study (OECD 423) in the rat.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.